Delivery accuracy of VMAT on two beam‐matched linacs provided by accelerated go live service
Journal of Applied Clinical Medical Physics · 2023
DOI: 10.1002/acm2.14071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2023. Verfasst von Masato Tsuneda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, MR Linac ART Division, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba, Japan. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Brain Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Introduction
Dosimetric accuracy is critical when a patient treated with volumetric modulated arc therapy (VMAT) is transferred to another beam‐matched linac. To evaluate the performance of Accelerated Go Live (AGL) service, the measured beam characteristics and patient specific quality assurance (QA) results between two AGL‐matched linacs were compared. Materials and Methods Two VersaHD linacs were installed using the AGL service. After the installation, the beam data such as percentage depth dose (PDD), lateral profiles and output factors for all photon beams were measured. Relative doses were also measured as a function of the multi‐leaf collimator (MLC) leaf gap width. Subsequently, VMAT plans were created for prostate, pelvis, head and neck, liver, lung cancers and multiple brain metastases. Dose distributions and point doses were measured by multi‐dimensional detectors and ionization chambers for patient specific quality assurance, and comparisons were made between the two linacs.
Results
Dose differences in PDDs were all within ± 1% except the entrance region, and the averaged gamma indices of the lateral profiles were within 0.3. The differences in doses as a function of the MLC leaf gap width between the two linacs were within ±0.5%. For all the plans, gamma passing rates were all higher than 95% with criteria of 2%/2 mm. The average and the SD of dose differences on the multi‐dimensional detector between both measurements was 0.06 ± 2.12%, and the average of point dose differences was −0.03 ± 0.33%.
Conclusion
We have evaluated the AGL performance in the context of beam characteristics and patient specific QA. It was demonstrated that the AGL service provides an accurate VMAT treatment reproducibility for many tumor sites with gamma pass rates greater than 95% under criteria of 2%/2 mm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, MR Linac ART Division, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba, Japan.
- Department of Radiation Sciences, Komazawa University, Setagaya-ku, Tokyo, Japan.
- Department of Radiology, Chiba University Hospital, Chuo-ku, Chiba, Japan.
- Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba, Japan.
ORCID-Profile: Masato Tsuneda
Förderung
- JSPS KAKENHI
Zitieren
APA
Tsuneda, M., Abe, K., Fujita, Y., Morimoto, R., Hashimoto, T., Abe, Y., & Uno, T. (2023). Delivery accuracy of VMAT on two beam‐matched linacs provided by accelerated go live service. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.14071
Vancouver
Tsuneda M, Abe K, Fujita Y, Morimoto R, Hashimoto T, Abe Y, et al. Delivery accuracy of VMAT on two beam‐matched linacs provided by accelerated go live service. Journal of Applied Clinical Medical Physics. 2023. doi:10.1002/acm2.14071
BibTeX
@article{Tsuneda2023,
author = {Tsuneda, Masato and Abe, Kota and Fujita, Yukio and Morimoto, Ryo and Hashimoto, Takuma and Abe, Yukinao and Uno, Takashi},
title = {Delivery accuracy of VMAT on two beam‐matched linacs provided by accelerated go live service},
journal = {Journal of Applied Clinical Medical Physics},
year = {2023},
doi = {10.1002/acm2.14071}
}
EUVIMED